208 related articles for article (PubMed ID: 6153827)
21. Treatment of cutaneous T-cell lymphomas with TP-5. Evaluation of the clinical effect in 8 patients.
Przybilla B; Burg G; Schmoeckel C; Braun-Falco O
Acta Derm Venereol; 1983; 63(6):524-9. PubMed ID: 6198843
[TBL] [Abstract][Full Text] [Related]
22. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
23. Target role of Langerhans cells in mycosis fungoides: transmission and immuno-electron microscopic studies.
Rowden G; Phillips TM; Lewis MG; Wilkinson RD
J Cutan Pathol; 1979 Oct; 6(5):364-82. PubMed ID: 316438
[TBL] [Abstract][Full Text] [Related]
24. A second look at intraepithelial Langerhans cells in mycosis fungoides and related disorders. Ultrastructural study with special reference to Langerhans granules and virus-like particles.
Füllbrandt U; Meissner K; Löning T; Jänner M
Virchows Arch A Pathol Anat Histopathol; 1983; 402(1):47-60. PubMed ID: 6419454
[TBL] [Abstract][Full Text] [Related]
25. [Mycosis fungoides].
Graciansky PD; Guilaine J
Ann Med Interne (Paris); 1975 Mar; 126(3):161-9. PubMed ID: 123718
[TBL] [Abstract][Full Text] [Related]
26. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
Schmitt D; Thivolet J
J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
[TBL] [Abstract][Full Text] [Related]
27. New techniques in the evaluation of cutaneous T-cell lymphoma.
van Vloten WA; Willemze R
Dermatol Clin; 1985 Oct; 3(4):665-72. PubMed ID: 3916173
[TBL] [Abstract][Full Text] [Related]
28. Nuclear and nucleolar ultrastructure of Sézary cells.
Smetana K; Daskal Y; Gyorkey F; Gyorkey P; Lehane DE; Rudolph AH; Busch H
Cancer Res; 1977 Jul; 37(7 Pt 1):2036-42. PubMed ID: 140762
[TBL] [Abstract][Full Text] [Related]
29. In vivo reflectance confocal microscopy of mycosis fungoides: A preliminary study.
Agero AL; Gill M; Ardigo M; Myskowski P; Halpern AC; González S
J Am Acad Dermatol; 2007 Sep; 57(3):435-41. PubMed ID: 17433849
[TBL] [Abstract][Full Text] [Related]
30. Epidermal Langerhans cells and prognosis of patients with mycosis fungoides and Sezary syndrome.
Meissner K; Löning T; Rehpenning W
In Vivo; 1993; 7(3):277-80. PubMed ID: 8357970
[TBL] [Abstract][Full Text] [Related]
31. [Epidermotropic T lymphomas].
Sigal-Nahum M; Brousse N; Belaïch S
Rev Prat; 1987 May; 37(25):1423-31. PubMed ID: 3495856
[No Abstract] [Full Text] [Related]
32. Ultrastructural observations of Pautrier microabscess.
Sagami S; Asano S; Takahashi M; Imabayashi K
J Dermatol; 1980 Apr; 7(2):113-9. PubMed ID: 6991566
[No Abstract] [Full Text] [Related]
33. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B
Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734
[TBL] [Abstract][Full Text] [Related]
34. Interdigitating reticulum cell and lymphoproliferative disease: possible correlations between skin and thymus-dependent lymphocyte system revisited.
Franchi F; Seminara P; Calvieri S
Acta Haematol; 1983; 70(3):154-7. PubMed ID: 6410641
[TBL] [Abstract][Full Text] [Related]
35. [The isolation and characteristics of long-term continuous lymphoid cell lines (IK-10 and IK-12) from patients with mycosis fungoides].
Parfenova TM; Faradzhev ZG; Kubanova AA; Shevliagin VIa; Chuvirov GN; Bykovskiĭ AF
Vestn Dermatol Venerol; 1990; (8):14-21. PubMed ID: 2256374
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous presentations of lymphoma in human immunodeficiency virus disease. Predominance of T cell lineage.
Kerschmann RL; Berger TG; Weiss LM; Herndier BG; Abrahms KM; Heon V; Schulze K; Kaplan LD; Resnik SD; LeBoit PE
Arch Dermatol; 1995 Nov; 131(11):1281-8. PubMed ID: 7503572
[TBL] [Abstract][Full Text] [Related]
37. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
Vinogradova IuE; Giliazitdinova EA; Zamulaeva IA; Zybunova EE; Kaplanskaia IB; Kravchenko SK; Kremenetskaia AM; Lutsenko IN; Samoĭlova RS; Selivanova EN; Sidorova IuV; Shklovskiĭ-Kord NE
Ter Arkh; 2005; 77(10):61-5. PubMed ID: 16320688
[TBL] [Abstract][Full Text] [Related]
38. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
[TBL] [Abstract][Full Text] [Related]
39. [Primary cutaneous malignant lymphoma -- Sézary syndrome].
Vuković I; Stojimirović E; Milutinović S
Bilt Hematol Transfuz; 1978; 6(3):57-62. PubMed ID: 757669
[TBL] [Abstract][Full Text] [Related]
40. The ultrastructural observation of a case of lymphomatoid papulosis.
Horiguchi Y; Horiguchi M; Toda K; Mitani T; Imamura S
Acta Derm Venereol; 1984; 64(4):308-15. PubMed ID: 6209888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
